Literature DB >> 28799090

Prostate cancer detection among readers with different degree of experience using ultra-high b-value diffusion-weighted Imaging: Is a non-contrast protocol sufficient to detect significant cancer?

D Hausmann1, N Aksöz2, J von Hardenberg3, T Martini4, N Westhoff3, S Buettner5, S O Schoenberg2, P Riffel2.   

Abstract

AIM: To evaluate the accuracy of a T2-weighted (T2w) - and a parallel transmit zoomed b = 2000 s/mm2 (b2000) - diffusion-weighted imaging sequence among three readers with different degrees of experience for prostate cancer (Pca) detection.
METHODS: Ninety-three patients with suspected Pca were enrolled. For b2000 a two-dimensional spatially-selective RF pulse using an echo-planar transmit trajectory was applied, and the field of view (FOV) was reduced to one-third. All three readers (Reader A: 7, B 4 and C <1 years of experience in prostate MRI) independently evaluated b2000 with regard to the presence of suspicious lesions that displayed increased signal. The results were compared to histopathology obtained by real-time MR/ultrasound fusion and systematic biopsy.
RESULTS: In 62 patients Pca was confirmed. One significant Pca (Gleason score (GS) 7b) was missed by Reader C. Overall, sensitivity/specificity/positive predictive value/negative predictive value were 90/71/86/79% for Reader A, 87/84/92/76% for Reader B and 85/74/87/72% for Reader C, respectively. Detection rates for significant Pca (GS >7a) were 100/100/94% for Readers A/B/C, respectively. Inter-reader agreement was generally good (Kappa A/B: 0.8; A/C: 0.82; B/C: 0.74).
CONCLUSION: B2000 in combination with a T2w could be useful to detect clinically significant Pca. KEY POINTS: • Significant prostate cancer using zoomed ultra-high b-value DWI was detected. • Diagnostic performance among readers with different degrees of experience was good. • mp- MRI of the prostate using a comprehensive non-contrast protocol is clinically feasible.

Entities:  

Keywords:  Diffusion-weighted imaging; Oncology; Prostate cancer; Ultra-high b-values; Zoomed-DWI

Mesh:

Year:  2017        PMID: 28799090     DOI: 10.1007/s00330-017-5004-8

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  36 in total

1.  Diffusion-weighted MRI of the prostate: advantages of Zoomed EPI with parallel-transmit-accelerated 2D-selective excitation imaging.

Authors:  Kolja M Thierfelder; Michael K Scherr; Mike Notohamiprodjo; Jakob Weiß; Olaf Dietrich; Ullrich G Mueller-Lisse; Josef Pfeuffer; Konstantin Nikolaou; Daniel Theisen
Journal:  Eur Radiol       Date:  2014-08-27       Impact factor: 5.315

2.  Clinical utility of apparent diffusion coefficient (ADC) values in patients with prostate cancer: can ADC values contribute to assess the aggressiveness of prostate cancer?

Authors:  Yasushi Itou; Katsuyuki Nakanishi; Yoshifumi Narumi; Yasuko Nishizawa; Hideaki Tsukuma
Journal:  J Magn Reson Imaging       Date:  2011-01       Impact factor: 4.813

3.  Quantitative evaluation of computed high B value diffusion-weighted magnetic resonance imaging of the prostate.

Authors:  Marnix C Maas; Jurgen J Fütterer; Tom W J Scheenen
Journal:  Invest Radiol       Date:  2013-11       Impact factor: 6.016

4.  Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent.

Authors:  Alexander Radbruch; Lukas D Weberling; Pascal J Kieslich; Oliver Eidel; Sina Burth; Philipp Kickingereder; Sabine Heiland; Wolfgang Wick; Heinz-Peter Schlemmer; Martin Bendszus
Journal:  Radiology       Date:  2015-04-06       Impact factor: 11.105

5.  Optimal high b-value for diffusion weighted MRI in diagnosing high risk prostate cancers in the peripheral zone.

Authors:  Harsh K Agarwal; Francesca V Mertan; Sandeep Sankineni; Marcelino Bernardo; Julien Senegas; Jochen Keupp; Dagane Daar; Maria Merino; Bradford J Wood; Peter A Pinto; Peter L Choyke; Baris Turkbey
Journal:  J Magn Reson Imaging       Date:  2016-07-07       Impact factor: 4.813

Review 6.  The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.

Authors:  Jonathan I Epstein; Lars Egevad; Mahul B Amin; Brett Delahunt; John R Srigley; Peter A Humphrey
Journal:  Am J Surg Pathol       Date:  2016-02       Impact factor: 6.394

7.  Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?

Authors:  Jennifer R Stark; Sven Perner; Meir J Stampfer; Jennifer A Sinnott; Stephen Finn; Anna S Eisenstein; Jing Ma; Michelangelo Fiorentino; Tobias Kurth; Massimo Loda; Edward L Giovannucci; Mark A Rubin; Lorelei A Mucci
Journal:  J Clin Oncol       Date:  2009-05-11       Impact factor: 44.544

8.  High-Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted Images: Evaluation of the Macrocyclic Gadolinium-Based Contrast Agent Gadobutrol.

Authors:  Alexander Radbruch; Lukas D Weberling; Pascal J Kieslich; Johanna Hepp; Philipp Kickingereder; Wolfgang Wick; Heinz-Peter Schlemmer; Martin Bendszus
Journal:  Invest Radiol       Date:  2015-12       Impact factor: 6.016

9.  Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.

Authors:  Hashim U Ahmed; Ahmed El-Shater Bosaily; Louise C Brown; Rhian Gabe; Richard Kaplan; Mahesh K Parmar; Yolanda Collaco-Moraes; Katie Ward; Richard G Hindley; Alex Freeman; Alex P Kirkham; Robert Oldroyd; Chris Parker; Mark Emberton
Journal:  Lancet       Date:  2017-01-20       Impact factor: 79.321

10.  ESUR prostate MR guidelines 2012.

Authors:  Jelle O Barentsz; Jonathan Richenberg; Richard Clements; Peter Choyke; Sadhna Verma; Geert Villeirs; Olivier Rouviere; Vibeke Logager; Jurgen J Fütterer
Journal:  Eur Radiol       Date:  2012-02-10       Impact factor: 5.315

View more
  6 in total

Review 1.  Diffusion-weighted imaging in prostate cancer.

Authors:  Tsutomu Tamada; Yu Ueda; Yoshiko Ueno; Yuichi Kojima; Ayumu Kido; Akira Yamamoto
Journal:  MAGMA       Date:  2021-09-07       Impact factor: 2.533

2.  Accelerated Segmented Diffusion-Weighted Prostate Imaging for Higher Resolution, Higher Geometric Fidelity, and Multi-b Perfusion Estimation.

Authors:  Pelin Aksit Ciris; Jr-Yuan George Chiou; Daniel I Glazer; Tzu-Cheng Chao; Clare M Tempany-Afdhal; Bruno Madore; Stephan E Maier
Journal:  Invest Radiol       Date:  2019-04       Impact factor: 6.016

3.  MRI features after prostatic artery embolization for the treatment of medium- and large-volume benign hyperplasia.

Authors:  Hongtao Zhang; Yanguang Shen; Jingjing Pan; Haiyi Wang; Yan Zhong; Yingwei Wang; Huiyi Ye
Journal:  Radiol Med       Date:  2018-05-12       Impact factor: 3.469

4.  Template for MR Visualization and Needle Targeting.

Authors:  Rui Li; Sheng Xu; Ivane Bakhutashvili; Ismail B Turkbey; Peter Choyke; Peter Pinto; Bradford Wood; Zion T H Tse
Journal:  Ann Biomed Eng       Date:  2018-11-28       Impact factor: 3.934

5.  Multiparametric MRI for Suspected Recurrent Prostate Cancer after HIFU:Is DCE still needed?

Authors:  Raïssa Lotte; Alexandre Lafourcade; Pierre Mozer; Pierre Conort; Eric Barret; Eva Comperat; Malek Ezziane; Paul-Hugo Jouve de Guibert; Sebastian Tavolaro; Lisa Belin; Franck Boudghene; Olivier Lucidarme; Raphaële Renard-Penna
Journal:  Eur Radiol       Date:  2018-04-09       Impact factor: 5.315

6.  Usefulness of Bi-Parametric Magnetic Resonance Imaging with b=1,800 s/mm² Diffusion-Weighted Imaging for Diagnosing Clinically Significant Prostate Cancer.

Authors:  Seung Soo Lee; Dong Hoon Lee; Won Hoon Song; Jong Kil Nam; Ji Yeon Han; Hyun Jung Lee; Tae Un Kim; Sung Woo Park
Journal:  World J Mens Health       Date:  2019-07-30       Impact factor: 5.400

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.